Oryzon to present at upcoming international conferences


• 2019 BioEquity Europe, Barcelona, Spain

• Chemical Biology Discussion Group Year-End Symposium, New York Academy of Sciences NYC, USA

• BIO International Convention 2019, Philadelphia, PA, USA

• Jefferies 2019 Global Healthcare Conference, New York, USA

• 24th Congress of the European Hematology Association, Amsterdam, The Netherlands


Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company will continue its institutional presence in several reputed international conferences in the upcoming weeks.


Click here to see the full Press Release